Thomas Eleveld - Dissemin

All papers authored by Thomas Eleveld

This paper is made freely available by the publisher.

2023 Thomas F. Eleveld

, Lindy Vernooij, Linda Schild, Bianca Koopmans, Lindy K. Alles, Marli E. Ebus, Rana Dandis, Harm van Tinteren, Huib N. Caron, Jan Koster, Max M. van Noesel, Lieve Godelieve A. M. Tytgat, Selma Eising, Rogier Versteeg, M. Emmy M. Dolman and 1 other authors

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

Download from doi.org

2022 Kaylee M. Keller, Thomas F. Eleveld

, Linda Schild, Kim van den Handel, Marlinde van den Boogaard, Vicky Amo-Addae, Selma Eising, Kimberley Ober, Bianca Koopmans, Leendert Looijenga, Godelieve A. M. Tytgat, Bauke Ylstra, Jan J. Molenaar, M. Emmy M. Dolman, Sander R. van Hooff

Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma

Download from doi.org

2021 Dennis M. Timmerman

, Thomas F. Eleveld

, Ad J. M. Gillis, Carlijn C. Friedrichs

, Sanne Hillenius

, Tessa L. Remmers

, Sruthi Sriram, Leendert H. J. Looijenga

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors

Download from doi.org

Caroline C. C. Hulsker

, Mariëtte E. G. Kranendonk, Thomas F. Eleveld

, Ad J. M. Gillis, Cornelis P. van de Ven, Natasha K. A. van Eijkelenburg

, Niels P. van der Kaaij

, Alida F. W. van der Steeg, Leendert H. J. Looijenga

Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy: A Complex Case Report

Download from doi.org

Thomas F. Eleveld

, Chaimaa Bakali, Paul P. Eijk, Phylicia Stathi, Lianne E. Vriend, Pino J. Poddighe, Bauke Ylstra

Engineering large-scale chromosomal deletions by CRISPR-Cas9

Download from academic.oup.com

This paper was not found in any repository, but could be made available legally by the author.

2020 Nil A. Schubert, Caitlin D. Lowery, Guillaume Bergthold, Jan Koster, Thomas F. Eleveld

, Ana Rodríguez, David T. W. Jones, Gilles Vassal, Louis F. Stancato, Stefan M. Pfister, Hubert N. Caron, Jan J. Molenaar

Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

T. F. Eleveld

, C. Bakali, P. P. Eijk, P. Stathi, P. J. Poddighe, B. Ylstra

Engineering large chromosomal deletions by CRISPR-Cas9

Upload

T. F. Eleveld

, L. Vernooij, L. Schild, B. Koopmans, L. K. Alles, M. E. Ebus, P. G. van Sluis, H. N. Caron, J. Koster, R. Versteeg, M. E. M. Dolman, J. J. Molenaar

MEK inhibition causes Bim stabilization and sensitivity to Bcl2 family member inhibitors in RAS-MAPK mutated neuroblastoma

Upload

2019 T. Eleveld

Additional mutations cause more aggressive tumors: MEK inhibitors offer opportunities when dealing with neuroblastoma tumors,MEK-remmers bieden kansen bij aanpak neuroblastoomtumoren

Upload

2018 Thomas F. Eleveld

, Linda Schild, Jan Koster

, Danny A. Zwijnenburg

, Lindy K. Alles, Marli E. Ebus, Richard Volckmann, Godelieve A. Tijtgat, Godelieve A. M. Tytgat, Peter van Sluis, Rogier Versteeg, Jan J. Molenaar

RAS-MAPK pathway-driven tumor progression is associated with loss of CIC and other genomic aberrations in neuroblastoma

Download from aacrjournals.org

2015 Thomas F. Eleveld

, Derek A. Oldridge, Virginie Bernard, Jan Koster, Leo Colmet Daage, Sharon J. Diskin, Linda Schild, Nadia Bessoltane Bentahar, Angela Bellini, Mathieu Chicard, Eve Lapouble, Valérie Combaret, Patricia Legoix-Né, Jean Michon, Trevor J. Pugh and 31 other authors

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Download from www.nature.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Thomas Eleveld